Athira Pharma Stock Price on December 20, 2024
| ATHA Stock | USD 0.58 0.03 5.45% |
Below is the normalized historical share price chart for Athira Pharma extending back to September 18, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Athira Pharma stands at 0.58, as last reported on the 23rd of December, with the highest price reaching 0.58 and the lowest price hitting 0.52 during the day.
If you're considering investing in Athira Stock, it is important to understand the factors that can impact its price. Athira Pharma appears to be dangerous, given 3 months investment horizon. Athira Pharma secures Sharpe Ratio (or Efficiency) of 0.085, which signifies that the company had a 0.085% return per unit of standard deviation over the last 3 months. By analyzing Athira Pharma's technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please makes use of Athira Pharma's risk adjusted performance of 0.0717, and Mean Deviation of 4.58 to double-check if our risk estimates are consistent with your expectations.
At present, Athira Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 190.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 33.7 M. . At present, Athira Pharma's Price Book Value Ratio is projected to increase based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.75, whereas Price Earnings Ratio is forecasted to decline to (0.82). Athira Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of September 2020 | 200 Day MA 1.8551 | 50 Day MA 0.5878 | Beta 2.835 |
Athira |
Sharpe Ratio = 0.085
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATHA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.67 actual daily | 68 68% of assets are less volatile |
Expected Return
| 0.65 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Athira Pharma is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Athira Pharma by adding it to a well-diversified portfolio.
Price Book 0.3868 | Book Value 3.411 | Enterprise Value -45.3 M | Enterprise Value Ebitda 1.3057 | Shares Float 27 M |
Related Headline
CytomX Therapeutics Headline on 20th of December 2024
Ultragenyx submits a BLA to the FDA seeking the accelerated approval of UX111 for patients with Sanfilippo syndrome type A in the United States.
Athira Pharma Valuation on December 20, 2024
It is possible to determine the worth of Athira Pharma on a given historical date. On December 20, 2024 Athira was worth 0.55 at the beginning of the trading date compared to the closed value of 0.58. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Athira Pharma stock. Still, in general, we apply an absolute valuation method to find Athira Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Athira Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Athira Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.54 | 0.56 | 0.53 | 0.55 | 348,198 | |
12/20/2024 | 0.55 | 0.58 | 0.52 | 0.58 | 222,548 |
| 0.55 | 0.58 | 0.52 | 0.58 | 0.00 |
| Backtest Athira Pharma | | | Athira Pharma History | | | Athira Pharma Valuation | Previous | Next |
Athira Pharma Trading Date Momentum on December 20, 2024
| On December 23 2024 Athira Pharma was traded for 0.58 at the closing time. The top price for the day was 0.58 and the lowest listed price was 0.52 . There was no trading activity during the period 0.0. Lack of trading volume on December 23, 2024 did not affect price variability. The overall trading delta against the current closing price is 5.17% . |
Athira Pharma Fundamentals Correlations and Trends
By evaluating Athira Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Athira Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Athira financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Athira Pharma Stock history
Athira Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Athira is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Athira Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Athira Pharma stock prices may prove useful in developing a viable investing in Athira Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38 M | 33.7 M | |
| Net Loss | -86.1 M | -81.8 M |
Athira Pharma Quarterly Net Working Capital |
|
Athira Pharma Stock Technical Analysis
Athira Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Athira Pharma Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Athira Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Athira Pharma December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Athira Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Athira Pharma shares will generate the highest return on investment. By undertsting and applying Athira Pharma stock market strength indicators, traders can identify Athira Pharma entry and exit signals to maximize returns
Athira Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Athira Pharma's price direction in advance. Along with the technical and fundamental analysis of Athira Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Athira to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0717 | |||
| Jensen Alpha | 0.5691 | |||
| Total Risk Alpha | 0.3819 | |||
| Sortino Ratio | 0.1195 | |||
| Treynor Ratio | 0.487 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Athira Stock analysis
When running Athira Pharma's price analysis, check to measure Athira Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athira Pharma is operating at the current time. Most of Athira Pharma's value examination focuses on studying past and present price action to predict the probability of Athira Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athira Pharma's price. Additionally, you may evaluate how the addition of Athira Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |